Clinical management and emerging therapies of FGFR3-related skeletal dysplasia in childhood. | Ann Pediatr Endocrinol Metab;27(2): 90-97, 2022 Jun. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Clinical management and emerging therapies of FGFR3-related skeletal dysplasia in childhood.

Kim, Hwa Young; Ko, Jung Min.

Affiliation

Kim HY; Department of Pediatrics, Seoul National University Children's Hospital, Seoul National University College of Medicine, Seoul, Korea.
Ko JM; Department of Pediatrics, Seoul National University Children's Hospital, Seoul National University College of Medicine, Seoul, Korea.

Ann Pediatr Endocrinol Metab ; 27(2): 90-97, 2022 Jun.

Article in En | MEDLINE | ID: mdl-35793999

Key words

Achondroplasia; CATSHL syndrome; FGFR3; Hypochondroplasia; SADDAN; Skeletal dysplasia; Thanatophoric dysplasia

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Ann Pediatr Endocrinol Metab Year: 2022 Document type: Article Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Ann Pediatr Endocrinol Metab Year: 2022 Document type: Article Country of publication: